Edinburgh Research Explorer

Estrogens protect male mice from obesity complications and influence glucocorticoid metabolism

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions



  • Download as Adobe PDF

    Rights statement: This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

    Final published version, 798 KB, PDF document

    Licence: Creative Commons: Attribution (CC-BY)

Original languageEnglish
JournalInternational Journal of Obesity
Publication statusPublished - 30 Jun 2015


BackgroundAlthough the prevalence of obesity is higher amongst women than men, they are somewhat protected from the associated cardiometabolic consequences. The increase in cardiovascular disease risk seen after the menopause suggests a role for estrogens. There is also growing evidence for the importance of estrogen on body fat and metabolism in males. We hypothesised that that estrogen administration would ameliorate the adverse effects of obesity on metabolic parameters in males.MethodsMale and female C57Bl/6 mice were fed control (CON) or obesogenic (DIO) diets from 5 weeks of age until adulthood. Glucose tolerance testing was performed at 13 weeks. Mice were killed at 15 weeks and liver and adipose tissue collected for analysis of gene expression. A second cohort of male mice underwent the same experimental design with the addition of estradiol pellet implantation or sham surgery at 6 weeks.ResultsDIO males had greater mesenteric adipose deposition and more severe increases in plasma glucose, insulin and lipids than females. Treatment of males with estradiol from 6 weeks of age prevented DIO-induced increases in adipose tissue mass and alterations in glucose-insulin homeostasis. We also identified sex differences in the transcript levels and activity of hepatic and adipose glucocorticoid metabolising enzymes. Estrogen treatment feminised the pattern of DIO-induced changes in glucocorticoid metabolism, rendering males similar to females.ConclusionsThus, DIO induces sex-specific changes in glucose-insulin homeostasis which are ameliorated in males treated with estrogen, highlighting the importance of sex steroids in metabolism. Given that altered peripheral glucocorticoid metabolism has been observed in rodent and human obesity, our results also suggest that sexually dimorphic expression and activity of glucocorticoid metabolising enzymes may play a role in the differential metabolic responses to obesity in males and females.International Journal of Obesity accepted article preview online, 02 June 2015. doi:10.1038/ijo.2015.102.

Download statistics

No data available

ID: 19826749